Cargando…

The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China

OBJECTIVE: To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases. METHODS: A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People’s Hospital (IMPH) from January 2018 to Decem...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jingjing, Yang, Guoxiang, Li, Siting, Luo, Yueming, Bai, Yina, Deng, Chuiwen, Song, Ning, Li, Mengtao, Zeng, Xiaofeng, Hu, Chaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552219/
https://www.ncbi.nlm.nih.gov/pubmed/36238277
http://dx.doi.org/10.3389/fimmu.2022.1007257
_version_ 1784806206546640896
author Meng, Jingjing
Yang, Guoxiang
Li, Siting
Luo, Yueming
Bai, Yina
Deng, Chuiwen
Song, Ning
Li, Mengtao
Zeng, Xiaofeng
Hu, Chaojun
author_facet Meng, Jingjing
Yang, Guoxiang
Li, Siting
Luo, Yueming
Bai, Yina
Deng, Chuiwen
Song, Ning
Li, Mengtao
Zeng, Xiaofeng
Hu, Chaojun
author_sort Meng, Jingjing
collection PubMed
description OBJECTIVE: To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases. METHODS: A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People’s Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively. RESULTS: The positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody. CONCLUSION: The RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification.
format Online
Article
Text
id pubmed-9552219
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95522192022-10-12 The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China Meng, Jingjing Yang, Guoxiang Li, Siting Luo, Yueming Bai, Yina Deng, Chuiwen Song, Ning Li, Mengtao Zeng, Xiaofeng Hu, Chaojun Front Immunol Immunology OBJECTIVE: To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases. METHODS: A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People’s Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively. RESULTS: The positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody. CONCLUSION: The RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification. Frontiers Media S.A. 2022-09-27 /pmc/articles/PMC9552219/ /pubmed/36238277 http://dx.doi.org/10.3389/fimmu.2022.1007257 Text en Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Meng, Jingjing
Yang, Guoxiang
Li, Siting
Luo, Yueming
Bai, Yina
Deng, Chuiwen
Song, Ning
Li, Mengtao
Zeng, Xiaofeng
Hu, Chaojun
The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China
title The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China
title_full The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China
title_fullStr The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China
title_full_unstemmed The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China
title_short The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China
title_sort clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: a retrospective study of two centers in china
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552219/
https://www.ncbi.nlm.nih.gov/pubmed/36238277
http://dx.doi.org/10.3389/fimmu.2022.1007257
work_keys_str_mv AT mengjingjing theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT yangguoxiang theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT lisiting theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT luoyueming theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT baiyina theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT dengchuiwen theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT songning theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT limengtao theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT zengxiaofeng theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT huchaojun theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT mengjingjing clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT yangguoxiang clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT lisiting clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT luoyueming clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT baiyina clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT dengchuiwen clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT songning clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT limengtao clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT zengxiaofeng clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina
AT huchaojun clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina